English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/59545
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorSarasquete, María Eugenia-
dc.contributor.authorGarcía-Sanz, Ramón-
dc.contributor.authorChillón, M. del Carmen-
dc.contributor.authorSantamaría, Carlos-
dc.contributor.authorLahuerta, Juan José-
dc.contributor.authorGonzález, Marcos-
dc.contributor.authorSan Miguel, Jesús F.-
dc.date.accessioned2012-11-06T11:18:26Z-
dc.date.available2012-11-06T11:18:26Z-
dc.date.issued2008-
dc.identifierdoi: 10.1182/blood-2008-04-147884-
dc.identifierissn: 0006-4971-
dc.identifiere-issn: 1528-0020-
dc.identifier.citationBlood 112(7): 2709-2712 (2008)-
dc.identifier.urihttp://hdl.handle.net/10261/59545-
dc.description.abstractWe have explored the potential role of genetics in the development of osteonecrosis of the jaw (ONJ) in multiple myeloma (MM) patients under bisphosphonate therapy. A genome-wide association study was performed using 500 568 single nucleotide polymorphisms (SNPs) in 2 series of homogeneously treated MM patients, one with ONJ (22 MM cases) and another without ONJ (65 matched MM controls). Four SNPs (rs1934951. rs1934980, rs1341162. and rs17110453) mapped within the cytochrome P450-2C gene (CYP2C8) showed a different distribution between cases and controls with statistically significant differences (P=1.07 × 10-6, P= 4.231 × 10-6, P= 6.22 × 10-6, and P=2.15 × 10-6, respectively). SNP rs1934951 was significantly associated with a higher risk of ONJ development even after Bonferroni correction (P corrected value=.02). Genotyping results displayed an overrepresentation of the T allele in cases compared with controls (48% vs 12%). Thus, individuals homozygous for the T allele had an increased likelihood of developing ONJ (odds ratio 12.75, 95% confidence interval 3.7-43.5) © 2008 by The American Society of Hematology.-
dc.description.sponsorshipThis work has been partially supported by grants PI06-1354 from the Spanish Fondo de Investigaciones Sanitarias de la Seguridad Social, Red Española de Cancer RD06/0020/0006, and with the support of the Hemato-Oncology Institut, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain.-
dc.language.isoeng-
dc.publisherAmerican Society of Hematology-
dc.rightsclosedAccess-
dc.titleBisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytoehrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis-
dc.typeArtículo-
dc.identifier.doi10.1182/blood-2008-04-147884-
dc.date.updated2012-11-06T11:18:26Z-
dc.description.versionPeer Reviewed-
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.